Position in GERN
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$2,560
+$2,557 QoQ
Shares Held
2,000
-16.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#235
of 259 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GERN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Avion Wealth holds $288,734 across 82 Biotechnology names. GERN ranks #31 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
53 | $26,326 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
500 | $17,695 | |
| 3 | EXEL |
Exelixis, Inc.
|
260 | $14,146 | |
| 4 | KOD |
Kodiak Sciences Inc.
|
352 | $13,713 | |
| 5 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
153 | $12,471 | |
| 6 | MRNA |
Moderna, Inc.
|
171 | $11,975 | |
| 7 | INCY |
Incyte Corp
|
105 | $11,902 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
55 | $10,300 |
All Filings in GERN
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,560 | 2,000 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $3 | 2,387 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $2 | 2,000 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $3,234 | 2,361 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $2 | 2,000 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $7 | 2,000 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $7,080 | 2,000 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $9,080 | 2,000 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $8,480 | 2,000 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $6,600 | 2,000 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $4,220 | 2,000 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $4,240 | 2,000 | Shares | Sole | 2023-10-20 | |
| No filing history on record for this holder in this stock. | ||||||